Crystalline bromodomain inhibitors
US9321765B2 · kind B2 · utility
17Cited by
0References
26Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 27, 2014 |
| Grant date | Apr 26, 2016 |
| Priority date | — |
| Expiry date | Jun 27, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
N-[4-(2,4-difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl]ethanesulfonamide and crystalline forms thereof are suitable pharmaceutical ingredients for pharmaceutical compositions useful in the treatment of disease, for example, cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.